Market Overview:
The global peficitinib market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cancer, increasing R&D expenditure by pharmaceutical companies, and growing demand for targeted therapies. However, the high cost of peficitinib may restrain the growth of this market to some extent. The global peficitinib market is segmented on the basis of type, application, and region. On the basis of type, it is divided into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. By application, it is classified into research and medical segments. Geographically, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (China Japan India South Korea Australia), and Middle East & Africa (Saudi Arabia UAE Qatar South Africa).
Product Definition:
Peficitinib is a novel, investigational small molecule JAK1 inhibitor with potential antineoplastic activity.
Min Purity Less Than 98%:
Min Purity Less Than 98% is a special range of chemicals, which contains more than 98% pure substance. It’s used in the production of pefectinib (CAS 944118-01-8). This chemical falls under the category of purine derivatives. Purine derivatives are compounds, which are derived from the breakdown of DNA and RNA. The most common types include xanthine and hypoxanthine.
Min Purity 98%-99%:
Min Purity 98%-99% is a special grade of Purified Water, which means it has passed through several purification processes to achieve the highest level of purity. It contains no additives and is suitable for producing high-purity chemicals.
It can be used in pharmaceuticals, chemical synthesis, food & beverage processing and other industries that require highly pure water or water with low contaminants such as suspended solids & organic compounds.
Application Insights:
Medical application of peicitinib accounted for the largest share of over 70.0% in 2017 owing to its extensive use as a radiosensitizer and radiopharmaceutical carrier in cancer treatment. It is also used as an imaging agent for the detection of breast cancer, lung cancer, and other cancers. The growing adoption of peicitinib radioisotope applications in medical oncology research is expected to drive demand over the forecast period.
The research segment is anticipated to witness significant growth during the study period owing to increasing R&D initiatives by various public and private institutions across the globe for developing new potential usespecifically focusing on solid tumors such as pancreatic, liver & biliary system cancers, melanoma skin tumor, thyroid tumor etc. This factor has ledto increased R&D spending by various market players which will further boost product demand globally during this forecast period.
Regional Analysis:
North America was the largest regional market for peficitinib in 2017. The growth of this region is attributed to the presence of a large number of key pharmaceutical and biopharmaceutical companies, which are engaged in drug development activities. Moreover, rising incidence rates of kidney diseases have led to an increase in demand for proteinuric drugs across this region.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing to factors such as increasing healthcare spending by governments and private sectors coupled with growing awareness about new generation therapeutics among patients & physicians. Furthermore, favorable government initiatives towards improving healthcare infrastructure are anticipated to fuel industry growth over here during the forecast period (2018 - 2030). For instance, ‘Make in India’ initiative undertaken by Indian government aims at promoting manufacturing output within country resulting into increased production capacity for generic drugs as well as branded ones (excluding those that infringe upon patents).
Growth Factors:
- Increasing demand for precision medicine
- Rising prevalence of cancer
- Growing geriatric population
- Technological advancements in oncology therapies 5. Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Peficitinib(CAS 944118-01-8) Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Cayman Chemical, Adooq Bioscience, BioVision, Biorbyt, MyBiosource, AbMole, Taiclone, Selleck Chemicals, BOC Sciences, Wuhan Sun-shine Bio-technology, MedKoo Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global Peficitinib(CAS 944118-01-8) Market Report Segments:
The global Peficitinib(CAS 944118-01-8) market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cayman Chemical
- Adooq Bioscience
- BioVision
- Biorbyt
- MyBiosource
- AbMole
- Taiclone
- Selleck Chemicals
- BOC Sciences
- Wuhan Sun-shine Bio-technology
- MedKoo Biosciences
Highlights of The Peficitinib(CAS 944118-01-8) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peficitinib(CAS 944118-01-8) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peficitinib is a drug that is used to treat cancer. It works by blocking the growth of cancer cells.
Some of the major players in the peficitinib(cas 944118-01-8) market are Cayman Chemical, Adooq Bioscience, BioVision, Biorbyt, MyBiosource, AbMole, Taiclone, Selleck Chemicals, BOC Sciences, Wuhan Sun-shine Bio-technology, MedKoo Biosciences.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peficitinib(CAS 944118-01-8) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Peficitinib(CAS 944118-01-8) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Peficitinib(CAS 944118-01-8) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Peficitinib(CAS 944118-01-8) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Peficitinib(CAS 944118-01-8) Market Size & Forecast, 2020-2028 4.5.1 Peficitinib(CAS 944118-01-8) Market Size and Y-o-Y Growth 4.5.2 Peficitinib(CAS 944118-01-8) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Peficitinib(CAS 944118-01-8) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Peficitinib(CAS 944118-01-8) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Peficitinib(CAS 944118-01-8) Market: Competitive Dashboard
14.2 Global Peficitinib(CAS 944118-01-8) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cayman Chemical
14.3.2 Adooq Bioscience
14.3.3 BioVision
14.3.4 Biorbyt
14.3.5 MyBiosource
14.3.6 AbMole
14.3.7 Taiclone
14.3.8 Selleck Chemicals
14.3.9 BOC Sciences
14.3.10 Wuhan Sun-shine Bio-technology
14.3.11 MedKoo Biosciences